Beyond infectious diseases, the Polymerase Chain Reaction (PCR) Market is heavily reliant on applications in complex medical fields and core research.

• Oncology: PCR is essential for cancer diagnosis and management. It is utilized for identifying cancer biomarkers, monitoring residual disease after treatment, and genotyping tumors to select appropriate targeted therapies (pharmacogenomics). The rising global incidence of cancer, coupled with increasing funding for cancer genomics, directly fuels the demand for high-precision PCR, especially dPCR.

• Genetic Disorders: The technology is critical for preimplantation genetic diagnosis (PGD), non-invasive prenatal screening (NIPS), and the detection of known genetic mutations associated with inherited disorders.

• Pharmaceutical and Biotech R&D: Pharmaceutical companies rely on Polymerase Chain Reaction for gene expression analysis, drug discovery validation, and quality control of biomanufactured products, ensuring continuous demand for the associated consumables and instruments in research institutions.

Reference: https://www.marketresearchfuture.com/reports/polymerase-chain-reaction-market-19212